Northland Securities Predicts Stronger Earnings for Transcat

Transcat, Inc. (NASDAQ:TRNS) – Investment analysts at Northland Securities raised their FY2026 earnings per share estimates for shares of Transcat in a research report issued to clients and investors on Wednesday, February 4th. Northland Securities analyst E. Jackson now forecasts that the scientific and technical instruments company will post earnings per share of $1.83 for the year, up from their prior forecast of $1.75. Northland Securities has a “Strong-Buy” rating on the stock. The consensus estimate for Transcat’s current full-year earnings is $2.30 per share. Northland Securities also issued estimates for Transcat’s Q4 2026 earnings at $0.55 EPS, FY2027 earnings at $1.86 EPS and FY2028 earnings at $2.15 EPS.

Other research analysts also recently issued reports about the stock. Zacks Research downgraded shares of Transcat from a “hold” rating to a “strong sell” rating in a research report on Tuesday. Weiss Ratings reiterated a “sell (d+)” rating on shares of Transcat in a research note on Monday, December 29th. One equities research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating and two have assigned a Sell rating to the company. Based on data from MarketBeat, Transcat currently has an average rating of “Hold” and a consensus price target of $105.33.

Transcat Stock Up 8.4%

TRNS stock opened at $76.33 on Thursday. The company has a fifty day moving average price of $60.23 and a 200 day moving average price of $68.44. Transcat has a 12 month low of $50.23 and a 12 month high of $97.08. The company has a market cap of $712.16 million, a price-to-earnings ratio of 89.80 and a beta of 0.79. The company has a debt-to-equity ratio of 0.34, a current ratio of 2.21 and a quick ratio of 2.06.

Transcat (NASDAQ:TRNS) last posted its quarterly earnings data on Tuesday, February 3rd. The scientific and technical instruments company reported $0.26 earnings per share for the quarter, missing the consensus estimate of $0.30 by ($0.04). The firm had revenue of $83.86 million during the quarter, compared to analyst estimates of $80.99 million. Transcat had a net margin of 2.47% and a return on equity of 6.15%.

Institutional Investors Weigh In On Transcat

A number of hedge funds have recently added to or reduced their stakes in TRNS. Conestoga Capital Advisors LLC increased its position in Transcat by 13.7% during the 2nd quarter. Conestoga Capital Advisors LLC now owns 1,088,471 shares of the scientific and technical instruments company’s stock worth $93,565,000 after purchasing an additional 131,217 shares during the period. Vanguard Group Inc. grew its holdings in Transcat by 0.4% during the third quarter. Vanguard Group Inc. now owns 530,771 shares of the scientific and technical instruments company’s stock worth $38,852,000 after acquiring an additional 2,041 shares during the period. Bessemer Group Inc. raised its position in Transcat by 35.8% in the second quarter. Bessemer Group Inc. now owns 244,491 shares of the scientific and technical instruments company’s stock worth $21,016,000 after acquiring an additional 64,422 shares in the last quarter. Geode Capital Management LLC lifted its holdings in Transcat by 1.8% in the second quarter. Geode Capital Management LLC now owns 223,202 shares of the scientific and technical instruments company’s stock valued at $19,189,000 after acquiring an additional 4,030 shares during the period. Finally, Bamco Inc. NY lifted its holdings in Transcat by 14.2% in the third quarter. Bamco Inc. NY now owns 191,566 shares of the scientific and technical instruments company’s stock valued at $14,023,000 after acquiring an additional 23,853 shares during the period. Institutional investors and hedge funds own 98.34% of the company’s stock.

Key Transcat News

Here are the key news stories impacting Transcat this week:

• Positive Sentiment: Northland raised near‑term estimates: Q4 2026 EPS was bumped to $0.55 (from $0.46), and FY2026 EPS was raised to $1.83 (from $1.75). These upgrades support stronger near‑term earnings expectations and likely helped lift the stock.
• Positive Sentiment: Northland also increased FY2027 and FY2028 EPS forecasts to $1.86 (from $1.70) and $2.15 (from $2.07), respectively — further evidence the firm sees improving performance over the next couple of years.
• Neutral Sentiment: Northland retains a “Strong‑Buy” rating and continues to publish multi‑year projections (FY2026–FY2030), which provides a bullish anchor for some institutional investors but also creates mixed signals because revisions vary by year.
• Negative Sentiment: Northland trimmed longer‑range estimates: FY2029 EPS was lowered to $2.89 (from $2.96) and FY2030 EPS to $3.18 (from $3.51). Those cuts suggest tempered longer‑term growth assumptions and may limit how far momentum can run.
• Negative Sentiment: Zacks Research downgraded TRNS from “Hold” to “Strong Sell,” adding a negative analyst voice that can pressure sentiment, especially among retail investors. Read more: Zacks.com TickerReport

Transcat Company Profile

Transcat, Inc (NASDAQ: TRNS) is a leading provider of calibration, laboratory, and metrology services in North America. Founded in 1964 and headquartered in Ronkonkoma, New York, the company specializes in ensuring the accuracy and compliance of measurement instruments across a wide range of industries. Transcat operates a network of ISO/IEC 17025–accredited laboratories and offers on-site field calibration, instrument repair, and preventive maintenance services.

In addition to its calibration services, Transcat distributes precision instrumentation and related software solutions from top manufacturers.